ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task - PubMed (original) (raw)
. 2009 Apr 1;8(7):1007-13.
doi: 10.4161/cc.8.7.8078. Epub 2009 Apr 4.
Affiliations
- PMID: 19279408
- DOI: 10.4161/cc.8.7.8078
ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task
Berta Casar et al. Cell Cycle. 2009.
Abstract
Signals transmitted by ERK1/2 MAP Kinases regulate the functions of multiple substrates present in the nucleus and in the cytoplasm, in similar proportions. In spite of this fact, the prevailing trend of the field has been to focus on the nuclear component, being considered the main executor of ERK biological functions. Following this fashion, scaffold proteins have been often described as modulators of ERK phosphorylation in their route, either as monomers or as dimers, to their ultimate destination at the nucleus. Contrarily, recent findings demonstrate that scaffolds and ERK dimers are essential for the activation of cytoplasmic but not nuclear substrates. Dimerization is critical for connecting the scaffolded ERK complex to cognate cytoplasmic substrates, while nuclear substrates are activated by ERK monomers. Furthermore, blocking ERK cytoplasmic signals by preventing ERK dimerization, is sufficient for attenuating cellular proliferation, transformation and tumor development. These new results highlight the importance of ERK cytoplasmic signals, disclose an unprecedented functional relationship between scaffold proteins and ERK dimers and identify dimerization as a key determinant of the spatial specificity of ERK signals.
Similar articles
- Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes.
Casar B, Pinto A, Crespo P. Casar B, et al. Mol Cell. 2008 Sep 5;31(5):708-21. doi: 10.1016/j.molcel.2008.07.024. Mol Cell. 2008. PMID: 18775330 - Analysis of ERKs' dimerization by electrophoresis.
Pinto A, Crespo P. Pinto A, et al. Methods Mol Biol. 2010;661:335-42. doi: 10.1007/978-1-60761-795-2_20. Methods Mol Biol. 2010. PMID: 20811993 - ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation.
Lidke DS, Huang F, Post JN, Rieger B, Wilsbacher J, Thomas JL, Pouysségur J, Jovin TM, Lenormand P. Lidke DS, et al. J Biol Chem. 2010 Jan 29;285(5):3092-102. doi: 10.1074/jbc.M109.064972. Epub 2009 Nov 17. J Biol Chem. 2010. PMID: 19920141 Free PMC article. - Regulatory mechanisms and function of ERK MAP kinases.
Torii S, Nakayama K, Yamamoto T, Nishida E. Torii S, et al. J Biochem. 2004 Nov;136(5):557-61. doi: 10.1093/jb/mvh159. J Biochem. 2004. PMID: 15632293 Review. - Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling.
Pouysségur J, Volmat V, Lenormand P. Pouysségur J, et al. Biochem Pharmacol. 2002 Sep;64(5-6):755-63. doi: 10.1016/s0006-2952(02)01135-8. Biochem Pharmacol. 2002. PMID: 12213567 Review.
Cited by
- The nuclear translocation of ERK1/2 as an anticancer target.
Plotnikov A, Flores K, Maik-Rachline G, Zehorai E, Kapri-Pardes E, Berti DA, Hanoch T, Besser MJ, Seger R. Plotnikov A, et al. Nat Commun. 2015 Mar 30;6:6685. doi: 10.1038/ncomms7685. Nat Commun. 2015. PMID: 25819065 - Contemporary biomedical engineering perspective on volitional evolution for human radiotolerance enhancement beyond low-earth orbit.
Borg AM, Baker JE. Borg AM, et al. Synth Biol (Oxf). 2021 Sep 2;6(1):ysab023. doi: 10.1093/synbio/ysab023. eCollection 2021. Synth Biol (Oxf). 2021. PMID: 34522784 Free PMC article. Review. - MEK inhibitors: a promising targeted therapy for cardiovascular disease.
Mohammed KAK, Madeddu P, Avolio E. Mohammed KAK, et al. Front Cardiovasc Med. 2024 Jul 1;11:1404253. doi: 10.3389/fcvm.2024.1404253. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39011492 Free PMC article. Review. - The ERK Cascade: Distinct Functions within Various Subcellular Organelles.
Wortzel I, Seger R. Wortzel I, et al. Genes Cancer. 2011 Mar;2(3):195-209. doi: 10.1177/1947601911407328. Genes Cancer. 2011. PMID: 21779493 Free PMC article. - "RAF" neighborhood: protein-protein interaction in the Raf/Mek/Erk pathway.
Cseh B, Doma E, Baccarini M. Cseh B, et al. FEBS Lett. 2014 Aug 1;588(15):2398-406. doi: 10.1016/j.febslet.2014.06.025. Epub 2014 Jun 14. FEBS Lett. 2014. PMID: 24937142 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous